TDOC:CA:TSX-TD Global Healthcare Leaders Index ETF (CAD)

ETF | Others |

Last Closing

CAD 19.7

Change

+0.20 (+1.03)%

Market Cap

CAD 0.08B

Volume

1.66K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

-0.28 (-0.80%)

CAD 6.78B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.02%)

CAD 6.30B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.27 (+0.96%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.22 (+1.00%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.42 (-1.13%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.66 (-1.43%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.36 (+1.38%)

CAD 3.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 3.55B
PSLV-U:CA Sprott Physical Silver Trust

+0.22 (+2.10%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.13 (+0.57%)

CAD 2.78B

ETFs Containing TDOC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.30% 91% A- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.30% 92% A 85% B
Trailing 12 Months  
Capital Gain 5.86% 40% F 40% F
Dividend Return 2.42% 51% F 37% F
Total Return 8.28% 38% F 37% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.41% 50% F 44% F
Dividend Return 3.63% 48% F 38% F
Total Return 0.22% 32% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 6.07% 75% C 88% B+
Risk Adjusted Return 59.84% 69% C- 68% D+
Market Capitalization 0.08B 58% F 31% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.